AKT1 and diabetes mellitus: Moreover, HIF1A is downregulated in the skin of diabetes patients; HIF1A overexpression in ADSCs-derived extracellular vehicles can promote the healing rate and treatment of diabetes patients via activating the PI3K/AKT pathway [29].